A citation-based method for searching scientific literature

McKenzie K Grundy, Ronald J Buckanovich, Kara A Bernstein. NAR Cancer 2020
Times Cited: 19







List of co-cited articles
170 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
36

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
31

BRCAness revisited.
Christopher J Lord, Alan Ashworth. Nat Rev Cancer 2016
664
31

Genomic instability--an evolving hallmark of cancer.
Simona Negrini, Vassilis G Gorgoulis, Thanos D Halazonetis. Nat Rev Mol Cell Biol 2010
26

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
26

Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.
Katharina Schlacher, Nicole Christ, Nicolas Siaud, Akinori Egashira, Hong Wu, Maria Jasin. Cell 2011
754
26

Identification of specific inhibitors of human RAD51 recombinase using high-throughput screening.
Fei Huang, Nuzhat A Motlekar, Chelsea M Burgwin, Andrew D Napper, Scott L Diamond, Alexander V Mazin. ACS Chem Biol 2011
124
26

Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.
Eva Petermann, Manuel Luís Orta, Natalia Issaeva, Niklas Schultz, Thomas Helleday. Mol Cell 2010
555
21

53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks.
Samuel F Bunting, Elsa Callén, Nancy Wong, Hua-Tang Chen, Federica Polato, Amanda Gunn, Anne Bothmer, Niklas Feldhahn, Oscar Fernandez-Capetillo, Liu Cao,[...]. Cell 2010
21

PARP inhibitors: Synthetic lethality in the clinic.
Christopher J Lord, Alan Ashworth. Science 2017
21

RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells.
Brian Budke, Hillary L Logan, Jay H Kalin, Anna S Zelivianskaia, William Cameron McGuire, Luke L Miller, Jeremy M Stark, Alan P Kozikowski, Douglas K Bishop, Philip P Connell. Nucleic Acids Res 2012
115
21


The multifaceted roles of PARP1 in DNA repair and chromatin remodelling.
Arnab Ray Chaudhuri, André Nussenzweig. Nat Rev Mol Cell Biol 2017
577
21

Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells.
Emilie Rass, Anastazja Grabarz, Isabelle Plo, Jean Gautier, Pascale Bertrand, Bernard S Lopez. Nat Struct Mol Biol 2009
233
15

RAD-ical New Insights into RAD51 Regulation.
Meghan R Sullivan, Kara A Bernstein. Genes (Basel) 2018
51
15

Repair of strand breaks by homologous recombination.
Maria Jasin, Rodney Rothstein. Cold Spring Harb Perspect Biol 2013
493
15

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.
Peter Bouwman, Amal Aly, Jose M Escandell, Mark Pieterse, Jirina Bartkova, Hanneke van der Gulden, Sanne Hiddingh, Maria Thanasoula, Atul Kulkarni, Qifeng Yang,[...]. Nat Struct Mol Biol 2010
672
15

Is non-homologous end-joining really an inherently error-prone process?
Mireille Bétermier, Pascale Bertrand, Bernard S Lopez. PLoS Genet 2014
235
15

Homologous recombination and the repair of DNA double-strand breaks.
William Douglass Wright, Shanaya Shital Shah, Wolf-Dietrich Heyer. J Biol Chem 2018
263
15

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.
Vassilis G Gorgoulis, Leandros-Vassilios F Vassiliou, Panagiotis Karakaidos, Panayotis Zacharatos, Athanassios Kotsinas, Triantafillos Liloglou, Monica Venere, Richard A Ditullio, Nikolaos G Kastrinakis, Brynn Levy,[...]. Nature 2005
15

Replication fork stability confers chemoresistance in BRCA-deficient cells.
Arnab Ray Chaudhuri, Elsa Callen, Xia Ding, Ewa Gogola, Alexandra A Duarte, Ji-Eun Lee, Nancy Wong, Vanessa Lafarga, Jennifer A Calvo, Nicholas J Panzarino,[...]. Nature 2016
439
15

A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia.
Jiewen Zhu, Longen Zhou, Guikai Wu, Heiko Konig, Xiaoqin Lin, Guideng Li, Xiao-Long Qiu, Chi-Fen Chen, Chun-Mei Hu, Erin Goldblatt,[...]. EMBO Mol Med 2013
59
15

Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells.
Marinella Roberti, Fabrizio Schipani, Greta Bagnolini, Domenico Milano, Elisa Giacomini, Federico Falchi, Andrea Balboni, Marcella Manerba, Fulvia Farabegoli, Francesca De Franco,[...]. Eur J Med Chem 2019
19
15

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.
C Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, A Llop-Guevara, Y H Ibrahim, A Gris-Oliver, S Bonache, B Morancho, A Bruna, O M Rueda,[...]. Ann Oncol 2018
163
15

Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer.
H Maacke, S Opitz, K Jost, W Hamdorf, W Henning, S Krüger, A C Feller, A Lopens, K Diedrich, E Schwinger,[...]. Int J Cancer 2000
155
15

Inhibition of homologous recombination in human cells by targeting RAD51 recombinase.
Fei Huang, Olga M Mazina, Isaac J Zentner, Simon Cocklin, Alexander V Mazin. J Med Chem 2012
82
15

Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.
Raphael Ceccaldi, Jessica C Liu, Ravindra Amunugama, Ildiko Hajdu, Benjamin Primack, Mark I R Petalcorin, Kevin W O'Connor, Panagiotis A Konstantinopoulos, Stephen J Elledge, Simon J Boulton,[...]. Nature 2015
423
15

Non-enzymatic roles of human RAD51 at stalled replication forks.
Jennifer M Mason, Yuen-Ling Chan, Ralph W Weichselbaum, Douglas K Bishop. Nat Commun 2019
49
15

Electrophilic fatty acids impair RAD51 function and potentiate the effects of DNA-damaging agents on growth of triple-negative breast cells.
Alparslan Asan, John J Skoko, Chen-Shan Chen Woodcock, Bentley M Wingert, Steven R Woodcock, Daniel Normolle, Yi Huang, Jeremy M Stark, Carlos J Camacho, Bruce A Freeman,[...]. J Biol Chem 2019
8
37

The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair.
Claus Storgaard Sørensen, Lasse Tengbjerg Hansen, Jaroslaw Dziegielewski, Randi G Syljuåsen, Cecilia Lundin, Jiri Bartek, Thomas Helleday. Nat Cell Biol 2005
486
15

Mechanism of eukaryotic homologous recombination.
Joseph San Filippo, Patrick Sung, Hannah Klein. Annu Rev Biochem 2008
15

Interstrand Crosslink Repair as a Target for HDAC Inhibition.
Teodora Nikolova, Nicole Kiweler, Oliver H Krämer. Trends Pharmacol Sci 2017
33
15

HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130.
Anja Göder, Claudia Emmerich, Teodora Nikolova, Nicole Kiweler, Maria Schreiber, Toni Kühl, Diana Imhof, Markus Christmann, Thorsten Heinzel, Günter Schneider,[...]. Nat Commun 2018
36
15

Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs.
Nancy Berte, Andrea Piée-Staffa, Nadine Piecha, Mengwan Wang, Kerstin Borgmann, Bernd Kaina, Teodora Nikolova. Mol Cancer Ther 2016
32
15

A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin.
David A Alagpulinsa, Srinivas Ayyadevara, Robert Joseph Shmookler Reis. Front Oncol 2014
47
15

Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors.
Fei Huang, Nadish Goyal, Katherine Sullivan, Kritika Hanamshet, Mikir Patel, Olga M Mazina, Charles X Wang, W Frank An, James Spoonamore, Shailesh Metkar,[...]. Nucleic Acids Res 2016
56
15

Tumour lineage shapes BRCA-mediated phenotypes.
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, Preethi Srinivasan, Shweta S Chavan, Noah D Friedman, Ezra Y Rosen, Allison L Richards, Nancy Bouvier, S Duygu Selcuklu,[...]. Nature 2019
166
15

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
15

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
V Abkevich, K M Timms, B T Hennessy, J Potter, M S Carey, L A Meyer, K Smith-McCune, R Broaddus, K H Lu, J Chen,[...]. Br J Cancer 2012
373
15

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation.
Tatiana Popova, Elodie Manié, Guillaume Rieunier, Virginie Caux-Moncoutier, Carole Tirapo, Thierry Dubois, Olivier Delattre, Brigitte Sigal-Zafrani, Marc Bollet, Michel Longy,[...]. Cancer Res 2012
336
15

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
749
15

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
Melinda L Telli, Kirsten M Timms, Julia Reid, Bryan Hennessy, Gordon B Mills, Kristin C Jensen, Zoltan Szallasi, William T Barry, Eric P Winer, Nadine M Tung,[...]. Clin Cancer Res 2016
425
15

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
Helen Davies, Dominik Glodzik, Sandro Morganella, Lucy R Yates, Johan Staaf, Xueqing Zou, Manasa Ramakrishna, Sancha Martin, Sandrine Boyault, Anieta M Sieuwerts,[...]. Nat Med 2017
423
15

Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents.
Nicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, Aron C Eklund, Qiyuan Li, Ruiyang Tian, Christian Bowman-Colin, Yang Li, April Greene-Colozzi, J Dirk Iglehart,[...]. Cancer Discov 2012
287
15

Purified human BRCA2 stimulates RAD51-mediated recombination.
Ryan B Jensen, Aura Carreira, Stephen C Kowalczykowski. Nature 2010
434
10

A role for BLM in double-strand break repair pathway choice: prevention of CtIP/Mre11-mediated alternative nonhomologous end-joining.
Anastazja Grabarz, Josée Guirouilh-Barbat, Aurélia Barascu, Gaëlle Pennarun, Diane Genet, Emilie Rass, Susanne M Germann, Pascale Bertrand, Ian D Hickson, Bernard S Lopez. Cell Rep 2013
55
10

BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance.
Joseph Nacson, John J Krais, Andrea J Bernhardy, Emma Clausen, Wanjuan Feng, Yifan Wang, Emmanuelle Nicolas, Kathy Q Cai, Rossella Tricarico, Xiang Hua,[...]. Cell Rep 2018
36
10

An Overview of the Molecular Mechanisms of Recombinational DNA Repair.
Stephen C Kowalczykowski. Cold Spring Harb Perspect Biol 2015
253
10

Identification and purification of two distinct complexes containing the five RAD51 paralogs.
J Y Masson, M C Tarsounas, A Z Stasiak, A Stasiak, R Shah, M J McIlwraith, F E Benson, S C West. Genes Dev 2001
280
10

The hallmarks of aging.
Carlos López-Otín, Maria A Blasco, Linda Partridge, Manuel Serrano, Guido Kroemer. Cell 2013
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.